- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02574065
Effects on Crying Time in Colicky Infants With the Supplementation of Lactobacillus Reuteri DSM 17938
Effects on Crying Time in Colicky Infants With the Supplementation of Lactobacillus Reuteri DSM 17938: A Randomized, Double Blind, Placebo-controlled Study
Infant colic is a common condition characterized by excessive crying. The otherwise healthy infant aged less than 3 months is difficult to console during the periods with crying. The condition is defined by modified Wessel's criteria i.e. crying for more than 3 hours of the day, for more than 3 days of the week for at least 1 week.
The description of infant colic hasalso been defined by Rome III diagnostic criteria andincludes infants from birth to 4 months of age,without failure to thrive, that are showing paroxysms of irritability, fussing or crying that starts and stops without obvious cause. The episodes last 3 or more hours/day and occur at least 3days/week for at least one week. The infant has no signs of central nervous system or intrinsic developmental difficulties, is normal on physical examination, and has normal growth patterns.
Although infant colic is considered to be self limiting it is a distressing problem for families. It is in fact one of the most common reasons why parents seek the advice of a paediatrician or family practitioner during their child's first 3 months of life Up to 20% of infants under three months are affected by infant colic.
Infant colic could have significant adverse effects on family quality of life and could even be a trigger for shaken baby syndrome. Parental perception associated with colicky complaints is therefor strongly recommended to be an outcome measure in trials of infantile colic.
Measurement of parental/family quality of life and parental perception of colic severity with the help of a Visual Analogue Scale (VAS) in a Polish study showed that the use of a probiotic, Lactobacillus reuteri DSM 17938, could improve the perceived problems.
The relationship between infant colic and gastroenterological, allergical and psychological disorders later in childhood was studied in a prospective study on 96 infants divided into two groups, colicky and non-colicky. The children diagnosed with infant colic, showed an increased susceptibility to recurrent abdominal pain, allergic and psychological disorders in childhood when they were 10 years old.
The aetiology of infantile colic seems to be multifactorialbut is,despite many years of research, still unknown. The intestinal microbiota differs between infants with and without colic and has therefore been suggested to have a potential role. Other possible explanations are for example gut motility disturbances, low-grade mucosal inflammation and visceral hypersensitivity.
Evidence suggests thatadministration of the probioticL. reuteri DSM 17938 might offer some benefit.L. reuteri DSM 17938 has been tested for its effect on crying in colicky infants and has been demonstrated to have a significantly favourable effect on crying time in fivetrials. One is a randomized trial that compared the probioticto Simethicone; three areplacebo controlled randomized double blind trials and yet another is a placebo controlled randomized, single blind, observational study. A fifth studydid not find any effect.
Combining the results in a meta-analysis from three double blind, placebo controlled randomized trials (published at the time of the analysis, including the neutral one) found that, compared with placebo, L. reuteri administration reduced crying time at day 21 with about 40 min.
Recently it has been documented in a clinical trial that prophylactic use of L. reuteriDSM 17938during the first three months of lifereduced the onset offunctional gastrointestinal disorders, particularly functional constipation, regurgitation and infantile colic.
In conclusion, the administration L. reuteri DSM 17938 may reduce the crying time in children with infantile colic, especially those fed predominantly or exclusively with breast milk. However, further randomized controlled studies, are required to be able develop recommendations in the management of infant colic.
The present trial is undertaken to further document the effect of L. reuteri DSM 17938 on crying in colicky infants.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200062
- Recruiting
- Children's Hospital of Shanghai
-
Contact:
- Ting Zhang, MD
- Phone Number: +86 18016487615
- Email: zhangt@shchildren.com.cn
-
Contact:
- Xiaoyu Pan
- Phone Number: +86-21-52976338
- Email: panxy@shchildren.com.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis according to modified Wessel's definition of infant colic i.e. crying for more than 3 hours of the day, for more than3 days of the week
- Full term infant, i.e. gestational age between 37 and 42 weeks
- Breast fed, either exclusively or predominantly, i.e. to more than 50%
- Birth weight 2500 - 4000g.
- Apgar score ≥7 at 5 minutes at birth
- Age from birth to 4 months of age
- Parent(s) willingness to postpone major changes in the infant feeding mode
- Parent(s) willingness and ability to fill in diary and questionnaires
- Written informed consent from parents
- Stated availability throughout the study period
Exclusion Criteria:
- Chronic illness or major medical problem
- Gastrointestinal disease
- Failure to thrive
- Use of antibiotics two weeks before randomisation and throughout the intervention period, both infant and mother
- Use of probiotics two weeks before randomisation and throughout the intervention period, both infant (infant formula and/or supplementation)and mother
- Use of proton pump inhibitors two weeks before randomisation and throughout the intervention period.
- Infant receiving solid foods, such as cereals, mashed fruits or vegetable puree
- Participation in other clinical trials
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: L. reuteri DSM 17938 group
L. reuteri DSM 17938 will be given at a dose of 100000000 colony forming units (CFU) per day in an oil formulation delivered from a drop bottle. In the active study product, freeze-dried L. reuteri is suspended in a mixture of pharmaceutical grade medium chain triglycerides and sunflower oil together with pharmaceutical grade silicon dioxide to give the product the correct rheological properties. Each day, at about the same time, the infants will be given 5 drops (1x100000000 CFU) of the study product in connection with feeding. |
Effects on crying time in colicky infants with the supplementation of Lactobacillus reuteri DSM 17938
|
Placebo Comparator: Placebo group
The placebo consists of an identical formulation without L. reuteri.
Each day, at about the same time, the infants will be given 5 drops placebo in connection with feeding.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Daily crying time will be measured at Day 7 through questionnaire finished by parents.
Time Frame: Day 7
|
50 evaluable infants in each group will be needed to detect (i.e.
get a two-sided p-value less than 5%) a 50 minutes difference in crying time between L. reuteri DSM 17938 and placebo group and with a 90 minutes standard deviation, and a power of 80%, two-sided hypothesis.
|
Day 7
|
Daily crying time will be measured at Day 14 through questionnaire finished by parents.
Time Frame: Day 14
|
50 evaluable infants in each group will be needed to detect (i.e.
get a two-sided p-value less than 5%) a 50 minutes difference in crying time between L. reuteri DSM 17938 and placebo group and with a 90 minutes standard deviation, and a power of 80%, two-sided hypothesis.
|
Day 14
|
Daily crying time will be measured at Day 21 through questionnaire finished by parents.
Time Frame: Day 21
|
50 evaluable infants in each group will be needed to detect (i.e.
get a two-sided p-value less than 5%) a 50 minutes difference in crying time between L. reuteri DSM 17938 and placebo group and with a 90 minutes standard deviation, and a power of 80%, two-sided hypothesis.
|
Day 21
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ting Zhang, MD, Shanghai Children's Hospital
Publications and helpful links
General Publications
- Hyman PE, Milla PJ, Benninga MA, Davidson GP, Fleisher DF, Taminiau J. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 2006 Apr;130(5):1519-26. doi: 10.1053/j.gastro.2005.11.065.
- Szajewska H, Gyrczuk E, Horvath A. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2013 Feb;162(2):257-62. doi: 10.1016/j.jpeds.2012.08.004. Epub 2012 Sep 14.
- Savino F, Bailo E, Oggero R, Tullio V, Roana J, Carlone N, Cuffini AM, Silvestro L. Bacterial counts of intestinal Lactobacillus species in infants with colic. Pediatr Allergy Immunol. 2005 Feb;16(1):72-5. doi: 10.1111/j.1399-3038.2005.00207.x.
- Savino F, Cresi F, Pautasso S, Palumeri E, Tullio V, Roana J, Silvestro L, Oggero R. Intestinal microflora in breastfed colicky and non-colicky infants. Acta Paediatr. 2004 Jun;93(6):825-9.
- Lucassen PL, Assendelft WJ, van Eijk JT, Gubbels JW, Douwes AC, van Geldrop WJ. Systematic review of the occurrence of infantile colic in the community. Arch Dis Child. 2001 May;84(5):398-403. doi: 10.1136/adc.84.5.398.
- WESSEL MA, COBB JC, JACKSON EB, HARRIS GS Jr, DETWILER AC. Paroxysmal fussing in infancy, sometimes called colic. Pediatrics. 1954 Nov;14(5):421-35. No abstract available.
- de Weerth C, Fuentes S, Puylaert P, de Vos WM. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics. 2013 Feb;131(2):e550-8. doi: 10.1542/peds.2012-1449. Epub 2013 Jan 14.
- Sung V, Hiscock H, Tang ML, Mensah FK, Nation ML, Satzke C, Heine RG, Stock A, Barr RG, Wake M. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ. 2014 Apr 1;348:g2107. doi: 10.1136/bmj.g2107.
- Savino F, Pelle E, Palumeri E, Oggero R, Miniero R. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics. 2007 Jan;119(1):e124-30. doi: 10.1542/peds.2006-1222.
- Abrahamsson TR, Jakobsson T, Bottcher MF, Fredrikson M, Jenmalm MC, Bjorksten B, Oldaeus G. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007 May;119(5):1174-80. doi: 10.1016/j.jaci.2007.01.007. Epub 2007 Mar 8.
- Barr RG, Kramer MS, Boisjoly C, McVey-White L, Pless IB. Parental diary of infant cry and fuss behaviour. Arch Dis Child. 1988 Apr;63(4):380-7. doi: 10.1136/adc.63.4.380.
- Chau K, Lau E, Greenberg S, Jacobson S, Yazdani-Brojeni P, Verma N, Koren G. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr. 2015 Jan;166(1):74-8. doi: 10.1016/j.jpeds.2014.09.020. Epub 2014 Oct 23.
- Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr. 2008 Jun;152(6):801-6. doi: 10.1016/j.jpeds.2007.11.005. Epub 2007 Dec 26.
- Indrio F, Di Mauro A, Riezzo G. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation--reply. JAMA Pediatr. 2014 Aug;168(8):778. doi: 10.1001/jamapediatrics.2014.368. No abstract available.
- Steutel NF, Benninga MA, Langendam MW, de Kruijff I, Tabbers MM. Reporting outcome measures in trials of infant colic. J Pediatr Gastroenterol Nutr. 2014 Sep;59(3):341-6. doi: 10.1097/MPG.0000000000000412.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CSUB0090
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Crying Time in Colicky Infants
-
KU LeuvenUnknownConcentration-Time Profiles in Stomach & Intestine.Belgium
-
Institut National de la Santé Et de la Recherche...CompletedReaction Time | Awareness | Change in Sustained AttentionFrance
-
Charite University, Berlin, GermanyWithdrawnWaiting-time in the Anaesthesia Admissions Ambulance
-
University of ZurichUniversity Children's Hospital, ZurichUnknownGut Microbiota and Sleep in InfantsSwitzerland
-
NHS Greater Glasgow and ClydeUnknown
-
Columbia UniversityChildren's Hospital of Philadelphia; National Institute of Nursing Research... and other collaboratorsCompletedInfants in Neonatal Intensive Care UnitsUnited States
-
xiaolong zhaoRecruitingArtificial Intelligence | Time in Range | Insulin TherapyChina
-
Ohio State UniversityEmory University; Nationwide Children's HospitalTerminated
-
Thomas Jefferson UniversityCompletedBubbles in Colon at Time of ColonoscopyUnited States
-
The University of Texas Health Science Center,...UnknownMalnutrition | Growth Failure | Nutrition | Nutrition Disorder, Infant | Growth Failure in Medically Complex Infants | Malnutrition in Medically Complex Infants | Nutrition in Medically Complex InfantsUnited States
Clinical Trials on L. reuteri DSM 17938
-
Innovacion y Desarrollo de Estrategias en SaludBioGaia ABCompletedIrritable Bowel SyndromeChile, Mexico
-
University of CopenhagenCompleted
-
Lama Medical Care s.r.o.BioGaia ABUnknownDyspepsia | H. Pylori InfectionSlovakia
-
Malo ClinicCompletedPeri-implant MucositisPortugal
-
Azienda Ospedaliera Specializzata in Gastroenterologia...Completed
-
University of CopenhagenCompletedPeriodontitis | Dental CariesDenmark
-
University of CopenhagenKarolinska InstitutetCompleted
-
University of CopenhagenHalmstad County HospitalUnknownPostoperative Complications
-
Aghia Sophia Children's Hospital of AthensBioGaia ABCompletedFunctional Abdominal Pain (FAP) in ChildrenGreece, Poland, Slovenia
-
Innovacion y Desarrollo de Estrategias en SaludBioGaia ABUnknown